Thrombosis and Inflammation in Acute Coronary Syndromes

Indexed in: EBSCO

Despite remarkable progress in fighting against myocardial infarction, the thrombotic complications of the coronary artery are still a significant cause of morbidity and mortality worldwide. ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Recurrent Thromboembolism

Pp. 67-77 (11)

Melda Comert, Guray Saydam and Fahri Sahin


Venous thromboembolism (VTE) is a common and preventable disorder which mostly manifests as deep-vein thrombosis of the legs. The incidence of VTE is 1 to 2 cases per 1000 persons in developed countries. After the first episode of VTE risk of recurrence increases in these patients, the cumulative rate of recurrence is about 25% and 30% at 5 years and 10 years respectively. Independent predictors of late recurrence include increasing patient age and body mass index, leg paresis, active cancer and other persistent VTE risk factors such as idiopathic VTE, antiphospholipid antibody syndrome, antithrombin, protein C or protein S deficiency, hyperhomocysteinemia and a persistently increased plasma fibrin D-dimer. The most important point during evaluation of VTE is not to forget that it is a multi-factorial status and can be caused by interaction between the systems which should be investigated carefully.


Acquired hypercoagulability, Activated Protein C Resistance, Antiphospholipid Syndrome, anti-thrombin, Clotting, Coagulation, D-dimer, Dysfibrinogenemia, Fibrin, Hyperhomocysteinemia, Inherited hypercoagulability, Platelets, protein C, protein S, Prothrombin gene mutation, recurrence, risk factors, Thrombin, thromboembolism, Thrombophila, thrombosis.


Ege University Hospital, Department of Hematology, 35100 Bornova, Izmir, Turkey.